Written By:
Dr. Nishant Wadhwa
Dr. Nishant Wadhwa
Published On: 05 Aug, 2023 1:05 PM | Updated On: 05 Aug, 2023 3:50 PM
Continuous Renal Replacement Therapy in Pediatric Patients with Hepatitis A Virus Associated ALF with Advanced Hepatic Encephalopathy – Effect on Survival
- Continuous renal replacement therapy (CRRT) is increasingly used for nonrenal indications in ICU.
- Early use of CRRT in acute liver failure (ALF) for hyperammonemia and HE III/IV is popular.
- However, only retrospective studies are available in ALF.
- Radionuclide computed tomography (RCT) on CRRT in nonrenal settings (septic shock) has shown no survival benefit.
- CRRT does not increase survival in ALF HE III/IV.
- CRRT does not affect bilirubin and inotrope requirement; decreases ammonia.
- KCH and failure to reduce ammonia are predictors of mortality.
- RCT is required to assess the effect of CRRT on survival.
Dr. Nishant Wadhwa
Dr. Nishant Wadhwa is an Pediatrician Associated with the Sir Ganga Ram Hospital in New Delhi.
Related FAQs
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article